RxDoctor Payments Data

Gina Volpe, DO

Family Medicine · North Canton, OHNPI 1386613768

Payments from drug & device makers

$6,763in general payments, 2019–2025

Across 456 payments — averaging $14.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • AstraZeneca$691
  • Lilly USA, LLC$589
  • Pfizer$448
  • Merck$323
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$6,763100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,763 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$75,175
Medicare patients
214
Services billed
2,105

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin119$137,954
EliquisApixaban92$73,007
FarxigaDapagliflozin Propanediol25$29,464
OzempicSemaglutide17$23,335
JanuviaSitagliptin Phosphate23$20,973
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$13,956
TrulicityDulaglutide11$13,057
Breo ElliptaFluticasone/Vilanterol22$11,805
Spiriva RespimatTiotropium Bromide11$11,703
ArexvyRsvpref3 Antigen/As01e/Pf30$9,327
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$7,085
Atorvastatin Calcium570$5,482
Levothyroxine Sodium439$4,518
ShingrixVaricella-Zoster Ge/As01b/Pf18$3,989
Rosuvastatin Calcium277$3,719

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$249$149,657130 claims
PfizerEliquis, Paxlovid$448$75,866103 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy, Anoro Ellipta, Shingrix$188$46,16296 claims
AstraZenecaFarxiga$691$29,46425 claims
Novo NordiskOzempic$1,056$23,33517 claims
MerckJanuvia$323$20,97323 claims
Lilly USA, LLCTrulicity$589$13,05711 claims
AbbVieSynthroid$1,200$2,05770 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in North Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →